GEMFIBROZIL Safety Questions, GEMFIBROZIL Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about GEMFIBROZIL. Our extensive database of GEMFIBROZIL adverse events and GEMFIBROZIL warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about GEMFIBROZIL

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet



GEMFIBROZIL Safety Reports

Total GEMFIBROZIL reports: 31.
GEMFIBROZIL FDA safety alerts: 2001 2003 .
   Reported hospitalizations: 16.
Take GEMFIBROZIL Side Effects Survey or Share Your GEMFIBROZIL Story. GEMFIBROZIL Usage.

Pharmacist from UNITED STATES reported GEMFIBROZIL problem on Jan 18, 2007. Male patient was diagnosed with hypertriglyceridaemia, atrial fibrillation and was treated with GEMFIBROZIL. After drug was administered, patient experienced the following problems/side effects: epistaxis, gout, hypertriglyceridaemia, international normalised ratio increased. GEMFIBROZIL dosage: 600 MG BID PO. During the same period patient was treated with WARFARIN, ALLOPURINOL, COMBIVENT, FUROSEMIDE, GLIPIZIDE, LISINOPRIL, METHYLPREDNISOLONE, METOPROLOL SUCCINATE. Patient was hospitalized. Patient recovered.

GEMFIBROZIL problem was reported by a Pharmacist from UNITED STATES on Jan 19, 2007. Male patient, 60 years of age, weighting 181.0 lb, was diagnosed with hyperlipidaemia and was treated with GEMFIBROZIL. After drug was administered, patient experienced the following problems/side effects: hepatotoxicity, muscular weakness, renal failure. GEMFIBROZIL dosage: 600MG BID PO. During the same period patient was treated with FLUVASTATIN, LISINOPRIL, METOPROLOL TARTRATE, FELODIPINE. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported GEMFIBROZIL problem on Jan 24, 2007. Male patient, 78 years of age, weighting 166.0 lb, was treated with GEMFIBROZIL. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme abnormal, rhabdomyolysis. GEMFIBROZIL dosage: unknown. During the same period patient was treated with LORATADINE, HYDRALAZINE, INSULIN, ISOSORBIDE MONONITRATE, AMLODIPINE BESYLATE, CLOPIDOGREL BISULPHATE. Patient was hospitalized. Patient recovered.

GEMFIBROZIL problem was reported by a Pharmacist from UNITED STATES on Jan 24, 2007. Male patient, 56 years of age, weighting 182.1 lb, was treated with GEMFIBROZIL. After drug was administered, patient experienced the following problems/side effects: nausea, vomiting. GEMFIBROZIL dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported GEMFIBROZIL problem on Jan 26, 2007. Male patient, 64 years of age, was diagnosed with hyperlipidaemia and was treated with GEMFIBROZIL. After drug was administered, patient experienced the following problems/side effects: agitation, irritability. GEMFIBROZIL dosage: 600MG BID PO. Patient recovered.

GEMFIBROZIL problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 29, 2007. Male patient, 58 years of age, was treated with GEMFIBROZIL. After drug was administered, patient experienced the following problems/side effects: impaired driving ability, road traffic accident. GEMFIBROZIL dosage: unknown. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported GEMFIBROZIL problem on Feb 05, 2007. Male patient, 61 years of age, weighting 233.0 lb, was treated with GEMFIBROZIL. After drug was administered, patient experienced the following problems/side effects: pancreatitis. GEMFIBROZIL dosage: unknown. Patient was hospitalized. Patient recovered.

GEMFIBROZIL problem was reported by a Pharmacist from UNITED STATES on Feb 07, 2007. Male patient, 49 years of age, weighting 255.1 lb, was diagnosed with mixed hyperlipidaemia and was treated with GEMFIBROZIL. After drug was administered, patient experienced the following problems/side effects: arthralgia. GEMFIBROZIL dosage: 600MG PO BID. During the same period patient was treated with AMOXICILLIN, SIMVASTATIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported GEMFIBROZIL problem on Feb 28, 2007. Female patient, weighting 124.0 lb, was diagnosed with hyperlipidaemia and was treated with GEMFIBROZIL. After drug was administered, patient experienced the following problems/side effects: gastric disorder. GEMFIBROZIL dosage: unknown. Patient recovered.

GEMFIBROZIL problem was reported by a Consumer or non-health professional from UNITED STATES on July 18, 2006. Female patient, 49 years of age, weighting 179.0 lb, was diagnosed with blood cholesterol increased and was treated with GEMFIBROZIL. After drug was administered, patient experienced the following problems/side effects: vision blurred. GEMFIBROZIL dosage: 600 MG, ORAL. During the same period patient was treated with SPIRONOLACTONE, NIFEDIPINE. Patient recovered.

Pharmacist from UNITED STATES reported GEMFIBROZIL problem on June 27, 2007. Male patient, 52 years of age, was treated with GEMFIBROZIL. After drug was administered, patient experienced the following problems/side effects: myalgia. GEMFIBROZIL dosage: 600MG BID PO. Patient recovered.

GEMFIBROZIL problem was reported by a Pharmacist from UNITED STATES on Aug 03, 2006. Male patient, 60 years of age, weighting 205.3 lb, was diagnosed with blood triglycerides, blood cholesterol and was treated with GEMFIBROZIL. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, fall. GEMFIBROZIL dosage: 600 MG PO BID. During the same period patient was treated with SIMVASTATIN. Patient was hospitalized. Patient recovered.

Physician from CROATIA (local name: Hrvatska) reported GEMFIBROZIL problem on Aug 02, 2006. Female patient, 61 years of age, was diagnosed with hypertriglyceridaemia, malignant melanoma and was treated with GEMFIBROZIL. After drug was administered, patient experienced the following problems/side effects: hepatitis. GEMFIBROZIL dosage: 600 MG, DAILY, ORAL. During the same period patient was treated with INTRON A, INTRON A, INTRON A, INTRON A. Patient recovered.

GEMFIBROZIL problem was reported by a Pharmacist from UNITED STATES on Aug 21, 2006. Female patient, 79 years of age, was diagnosed with hyperlipidaemia and was treated with GEMFIBROZIL. After drug was administered, patient experienced the following problems/side effects: rhabdomyolysis. GEMFIBROZIL dosage: 600MG BID PO. During the same period patient was treated with SIMVASTATIN, TRICOR, COZAAR, NORVASC, TOPROL, FUROSEMIDE, ASPIRIN. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported GEMFIBROZIL problem on Sept 28, 2006. Male patient, 53 years of age, weighting 184.1 lb, was diagnosed with hypertriglyceridaemia, cellulitis and was treated with GEMFIBROZIL. After drug was administered, patient experienced the following problems/side effects: abdominal pain, chest pain, diarrhoea, faeces discoloured, gingival pain, nausea, oral intake reduced, rhabdomyolysis. GEMFIBROZIL dosage: 600MG DAILY PO. During the same period patient was treated with MOXIFLOXACIN, METFORMIN. Patient was hospitalized and became disabled. Patient recovered.

GEMFIBROZIL problem was reported by a Pharmacist from UNITED STATES on Oct 12, 2006. Male patient, 51 years of age, weighting 120.2 lb, was diagnosed with hypertriglyceridaemia and was treated with GEMFIBROZIL. After drug was administered, patient experienced the following problems/side effects: rash. GEMFIBROZIL dosage: 1200MG, 600 MG BID, ORAL. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported GEMFIBROZIL problem on Oct 17, 2006. Male patient, 74 years of age, was diagnosed with hypercholesterolaemia and was treated with GEMFIBROZIL. After drug was administered, patient experienced the following problems/side effects: rhabdomyolysis. GEMFIBROZIL dosage: unknown. During the same period patient was treated with VYTORIN, COUMADIN, TOPROL, LISINOPRIL, ALLOPURINOL, ASPIRIN, GLUCOPHAGE, CALCIUM CARBONATE. Patient was hospitalized. Patient recovered.

GEMFIBROZIL problem was reported by a Pharmacist from UNITED STATES on Oct 17, 2006. Male patient, 71 years of age, weighting 266.1 lb, was diagnosed with hyperlipidaemia and was treated with GEMFIBROZIL. After drug was administered, patient experienced the following problems/side effects: rhabdomyolysis. GEMFIBROZIL dosage: 300MG PO BID. During the same period patient was treated with SIMVASTATIN. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported GEMFIBROZIL problem on Oct 17, 2006. Male patient, 80 years of age, weighting 212.1 lb, was diagnosed with hyperlipidaemia and was treated with GEMFIBROZIL. After drug was administered, patient experienced the following problems/side effects: rhabdomyolysis. GEMFIBROZIL dosage: 600MG PO BID. During the same period patient was treated with SIMVASTATIN. Patient was hospitalized. Patient recovered.

GEMFIBROZIL problem was reported by a Physician from FRANCE on Oct 03, 2006. Male patient, 55 years of age, weighting 154.3 lb, was treated with GEMFIBROZIL. After drug was administered, patient experienced the following problems/side effects: angina pectoris, apnoea, coronary artery stenosis, coronary artery thrombosis. GEMFIBROZIL dosage: unknown. During the same period patient was treated with SULFASALAZINE, INDOMETHACIN, CRIXIVAN, EPIVIR, ZERIT. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported GEMFIBROZIL problem on Oct 19, 2006. Male patient, 47 years of age, weighting 265.0 lb, was treated with GEMFIBROZIL. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme abnormal, myalgia. GEMFIBROZIL dosage: unknown. During the same period patient was treated with RANITIDINE, TEMAZEPAM, FENTANYL, POTASSIUM CHLORIDE, DIAZEPAM, LORAZEPAM, CITALOPRAM HYDROBROMIDE, ONDANSETRON. Patient was hospitalized. Patient recovered.

GEMFIBROZIL problem was reported by a Consumer or non-health professional from FRANCE on Oct 26, 2006. Male patient, 51 years of age, was treated with GEMFIBROZIL. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, arthropathy, asthenia, dysphagia, muscular weakness, myalgia, skin reaction, urticaria. GEMFIBROZIL dosage: unknown. During the same period patient was treated with METRONIDAZOLE. Patient recovered.

Pharmacist from UNITED STATES reported GEMFIBROZIL problem on Nov 14, 2006. Female patient was diagnosed with blood triglycerides increased and was treated with GEMFIBROZIL. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, hearing impaired, nausea, tinnitus, vertigo, vomiting. GEMFIBROZIL dosage: ONE 600MG TABLET BY MOUTH TWICE A DAY. Patient recovered.

GEMFIBROZIL problem was reported by a Pharmacist from UNITED STATES on Dec 01, 2006. Male patient, 54 years of age, weighting 209.4 lb, was diagnosed with hypertriglyceridaemia and was treated with GEMFIBROZIL. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, myalgia, pain in extremity. GEMFIBROZIL dosage: 600MG BY MOUTH TWICE DAILY. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported GEMFIBROZIL problem on Dec 07, 2006. Male patient, weighting 200.0 lb, was diagnosed with blood triglycerides increased, atrial fibrillation and was treated with GEMFIBROZIL. After drug was administered, patient experienced the following problems/side effects: blood triglycerides increased, epistaxis, international normalised ratio increased. GEMFIBROZIL dosage: 600 MG BID PO. During the same period patient was treated with WARFARIN, SPIRONOLACTONE, DIGITEK, FUROSEMIDE, COREG, HYDRALAZINE, ISOSOBIDE MONO, AMIODARONE. Patient recovered.

GEMFIBROZIL problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 18, 2006. Male patient, 47 years of age, weighting 267.0 lb, was diagnosed with blood cholesterol increased, blood triglycerides increased and was treated with GEMFIBROZIL. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia, myositis, rectal haemorrhage, rhabdomyolysis. GEMFIBROZIL dosage: 600 MG B.I.D. PO. During the same period patient was treated with LIPITOR. Patient recovered.

Consumer or non-health professional from GREECE reported GEMFIBROZIL problem on Dec 06, 2006. Male patient, 56 years of age, was diagnosed with hypercholesterolaemia and was treated with GEMFIBROZIL. After drug was administered, patient experienced the following problems/side effects: bipolar i disorder, condition aggravated. GEMFIBROZIL dosage: 1200 MG (600 MG, 2 IN 1 D), ORAL. During the same period patient was treated with ZOLPIDEM TARTRATE, HYPNOSEDON. Patient recovered.

GEMFIBROZIL problem was reported by a Pharmacist from UNITED STATES on July 03, 2007. Male patient, 65 years of age, was diagnosed with hyperlipidaemia and was treated with GEMFIBROZIL. After drug was administered, patient experienced the following problems/side effects: myalgia. GEMFIBROZIL dosage: 600MG BID PO. Patient recovered.

Consumer or non-health professional from UNITED STATES reported GEMFIBROZIL problem on July 20, 2007. Female patient, 55 years of age, was treated with GEMFIBROZIL. After drug was administered, patient experienced the following problems/side effects: fatigue, pharyngeal oedema. GEMFIBROZIL dosage: 600 MG BID PO. Patient recovered.

GEMFIBROZIL problem was reported by a Pharmacist from UNITED STATES on Aug 03, 2007. Male patient, 56 years of age, was diagnosed with hyperlipidaemia and was treated with GEMFIBROZIL. After drug was administered, patient experienced the following problems/side effects: renal failure acute, rhabdomyolysis. GEMFIBROZIL dosage: 600MG BID PO. During the same period patient was treated with SIMVASTATIN. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported GEMFIBROZIL problem on Sept 17, 2007. Male patient, 62 years of age, was diagnosed with hyperlipidaemia and was treated with GEMFIBROZIL. After drug was administered, patient experienced the following problems/side effects: abdominal pain, alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, chromaturia, muscular weakness. GEMFIBROZIL dosage: 600MG BID PO. During the same period patient was treated with SIMVASTATIN. Patient recovered.

Ask Our Patient Community about GEMFIBROZIL

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert (aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol
Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol
Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

 F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
HaloperidolThis drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant
Insulin Glulisine recombinant
Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
LinezolidThis drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant
Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert
PhenerganThis drug has as active FDA Safety Alert (promethazine)
Pimecrolimus
PioglitazoneThis drug has as active FDA Safety Alert
Placidyl (ethchlorvynol)
Plan B (levonorgestrel)
Pletal (cilostazol)
Poractant alfa
Posaconazole
Pramlintide Acetate
Precedex (dexmedetomidine)
PregabalinThis drug has as active FDA Safety Alert
Prezista (darunavir)
Prialt (ziconotide)
Priftin (rifapentine)
PrinivilThis drug has as active FDA Safety Alert (lisinopril)
ProcritThis drug has as active FDA Safety Alert (epoetin alfa)
ProHanceThis drug has as active FDA Safety Alert (gadoteridol)
PromethazineThis drug has as active FDA Safety Alert
PropofolThis drug has as active FDA Safety Alert
Prosom (estazolam)
Protonix (pantoprazole)
Protopic (tacrolimus)
Provigil (modafinil)
ProzacThis drug has as active FDA Safety Alert (fluoxetine)
Prussian blue


back to top

 Q
Quazepam
Quetiapine
QuinaprilThis drug has as active FDA Safety Alert
Quinupristin

R
Rabeprazole
Radiogardase (prussian blue)
Ramelteon
RamiprilThis drug has as active FDA Safety Alert
Ranexa (ranolazine)
Ranibizumab
Ranolazine
Rapamune (sirolimus)
Raptiva (efalizumab)
Rasagiline
RazadyneThis drug has as active FDA Safety Alert (galantamine)
Rebetol (ribavirin)
ReclastThis drug has as active FDA Safety Alert (zoledronic acid)
Refludan (lepirudin recombinant)
Relenza (zanamivir)
RelpaxThis drug has as active FDA Safety Alert (eletriptan)
RemeronThis drug has as active FDA Safety Alert (mirtazapine)
Renagel (sevelamer)
Rescula (unoprostone isopropyl)
Restoril (temazepam)
Revatio (sildenafil)
Revlimid (lenalidomide)
Reyataz (atazanavir sulfate)
Ribasphere (ribavarin ribasphere)
Ribavarin ribasphere
Rifapentine
Rifaximin
RisedronateThis drug has as active FDA Safety Alert
Risperdal (risperidone)
Risperidone
Ritalin (methylphenidate)
Ritonavir
RituxanThis drug has as active FDA Safety Alert
RituximabThis drug has as active FDA Safety Alert
Rivastigmine tartrate
RizatriptanThis drug has as active FDA Safety Alert
RocephinThis drug has as active FDA Safety Alert (ceftriaxone)
Rofecoxib
RosuvastatinThis drug has as active FDA Safety Alert
Rozerem (ramelteon)

back to top

S
Sacrosidase
Salmeterol xinafoate
Sanctura (trospium)
Seconal (secobarbital)
Secobarbital
Selzentry
Sensipar (cinacalcet)
Serevent Diskus (salmeterol xinafoate)
Seroquel (quetiapine)
Sertaconazole
SertralineThis drug has as active FDA Safety Alert
SerzoneThis drug has as active FDA Safety Alert (nefazodone)
Sevelamer
Sildenafil citrate
Sirolimus
Simvastatin
Sitagliptin phosphate
SkelidThis drug has as active FDA Safety Alert (tiludronate)
Sodium ferric gluconate complex
Sodium phosphatesThis drug has as active FDA Safety Alert
Solage (mequinol; tretinoin)
Soliris (eculizumab)
Solifenacin succinate
Somavert (pegvisomant)
Sonata (zaleplon)
Sorafenib
SotretThis drug has as active FDA Safety Alert (isotretinoin)
Spectracef (cefditoren pivoxil)
Spiriva (tiotropium bromide)
Sprycel (dasatinib)
Starlix (nateglinide)
Stimate Nasal SprayThis drug has as active FDA Safety Alert(desmopressin)
StratteraThis drug has as active FDA Safety Alert (atomoxetine)
Sucraid (sacrosidase)
SumatriptanThis drug has as active FDA Safety Alert
Sunitinib
Sustiva (efavirenz)
Sutent (sunitinib)
SymbyaxThis drug has as active FDA Safety Alert (olanzapine/fluoxetine)
Symlin (pramlintide acetate)
Synercid (quinupristin; dalfopristin)

back to top

T
Tacrolimus
Tadalafil
Tamiflu (oseltamivir phosphate)
Tasmar (tolcapone)
Targretin (bexarotene)
Technetium Tc 99m apcitide
Technetium Tc 99m depreotide
Tegaserod maleate
TegretolThis drug has as active FDA Safety Alert (carbamazepine)
Telbivudine
Telithromycin
Telmisartan
Temazepam
Temodar (temozolomide)
Temozolomide
TequinThis drug has as active FDA Safety Alert (gatifloxacin)
Thalidomide
Thalomid (thalidomide)
Thyrogen (thyrotropin alfa)
Thyrotropin alfa
TiagabineThis drug has as active FDA Safety Alert
Tigecycline
Tikosyn (dofetilide)
TiludronateThis drug has as active FDA Safety Alert
Tindamax (tinidazole)
Tinidazole
Tinzaparin
Tiotropium bromide
Tipranavir
Tirofiban
Tobramycin
Tolcapone
Tolterodine tartrate
Topical Anesthetics
TopiramateThis drug has as active FDA Safety Alert
TopamaxThis drug has as active FDA Safety Alert (Topiramate)
TrandolaprilThis drug has as active FDA Safety Alert
Trasylol (aprotinin)
Travatan (travoprost)
Travoprost
Triazolam
TrileptalThis drug has as active FDA Safety Alert (oxcarbazepine)
Trisenox (arsenic trioxide)
Tretinoin
Trospium
Tygacil (tigecycline)
Trypan Blue Ophthalmic Solution
Tyzeka (telbivudine)

back to top

U
Unithroid (levothyroxine sodium)
UnivascThis drug has as active FDA Safety Alert (moexipril)
Unoprostone isopropyl
Uroxatral (alfuzosin)

V
ValdecoxibThis drug has as active FDA Safety Alert
Valproate